LLM Reference

GPT-Rosalind Models by OpenAI

OpenAIProprietary
1 model2026

About

GPT-Rosalind is OpenAI's specialized frontier reasoning model for life sciences research. Released April 16, 2026 as a restricted research access model for biology, drug discovery, and translational medicine workflows. Part of OpenAI's strategy of purpose-built vertical AI models following GPT-5.4-Cyber for cybersecurity.

Current Variants

Use-when guidance is derived from seed capabilities, context, release, and replacement fields.

1 in view

Use when the workload needs medical, reasoning, and tool use.

2026-04medicalreasoningtool use

Release Timeline

1 release group
2026-04
1 current
GPT-Rosalind
medicalreasoningtool use
Current

Specifications(1 models)

GPT-Rosalind model specifications comparison
ModelReleasedReasoningFn CallingTool Use
GPT-Rosalind2026-04YesYesYes

Frequently Asked Questions

What is GPT-Rosalind used for?
GPT-Rosalind is used for medical, life sciences, and reasoning. The family description and listed model capabilities point to those workloads as the best fit.
How does GPT-Rosalind compare to GPT Realtime 2?
GPT-Rosalind by OpenAI is strongest where you need medical, while GPT Realtime 2 by OpenAI is the closest related family to check for translation. GPT-Rosalind has 1 listed variant, while GPT Realtime 2 reaches up to 131k context, so compare the specs and pricing tables before choosing a production model.
Which GPT-Rosalind model should I use?
If price is the main constraint, use the pricing table first because GPT-Rosalind does not have complete provider pricing in the local data. For the most capable/latest local choice, evaluate GPT-Rosalind with reasoning, tool use, and function calling.

Models(1)